Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1013 | 878 | 1013 | 1052 | 1457 | 2064 |
Fund Return | 1.27% | -12.25% | 1.27% | 1.71% | 7.81% | 7.51% |
Place in category | 104 | 159 | 104 | 34 | 22 | 44 |
% in Category | 55 | 85 | 55 | 14 | 11 | 40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Putnam Stable Value Fund: 50bps | 447.51M | 3.55 | 2.91 | 2.17 | ||
Putnam Stable Value Fund: 15bps | 16.4B | 3.91 | 3.27 | 2.53 | ||
Putnam Stable Value Fund: 20bps | 1.23B | 3.86 | 3.22 | 2.48 | ||
Putnam Stable Value Fund: 25bps | 5.13B | 3.81 | 3.17 | 2.43 | ||
Putnam Stable Value Fund: 35bps | 120.93M | 3.70 | 3.07 | 2.32 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Health Care Adm | 34.29B | -1.53 | 0.93 | 7.31 | ||
Fidelity Select Health Care | 10.35B | 4.93 | -1.61 | 8.22 | ||
T. Rowe Price Health Sciences | 8.1B | 1.82 | -2.69 | 8.69 | ||
Fidelity Advisor Health Care A | 6.23B | 3.90 | -2.12 | 7.40 | ||
Fidelity Advisor Health Care C | 6.23B | 3.12 | -2.86 | 6.60 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 11.86 | 811.08 | -1.48% | |
UnitedHealth | US91324P1021 | 10.13 | 542.49 | -0.56% | |
AbbVie | US00287Y1091 | 6.61 | 183.90 | +4.70% | |
Novo Nordisk B | DK0062498333 | 5.78 | 607.3 | +0.60% | |
AstraZeneca | GB0009895292 | 5.38 | 11,344.0 | +0.27% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Sell | Sell |
Technical Indicators | Strong Buy | Strong Sell | Strong Sell |
Summary | Strong Buy | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review